<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00209326</url>
  </required_header>
  <id_info>
    <org_study_id>FE200440 CS004</org_study_id>
    <nct_id>NCT00209326</nct_id>
  </id_info>
  <brief_title>A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor</brief_title>
  <official_title>A Randomised, Double-blind, Parallel Group, Dose-ranging, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women With Advanced Gestational Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferring Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      • To determine the effects of four different single bolus doses of FE200440 administered&#xD;
      intravenously on stopping preterm labour compared to placebo in pregnant women with advanced&#xD;
      gestational age&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  To determine the effects of four different single bolus doses of FE200440 administered&#xD;
           intravenously on stopping preterm labour compared to placebo in pregnant women with&#xD;
           advanced gestational age&#xD;
&#xD;
        -  To establish the effects of four different single bolus doses of FE200440 administered&#xD;
           intravenously on uterine contractions compared to placebo&#xD;
&#xD;
        -  To evaluate the effects of four different single bolus doses of FE200440 administered&#xD;
           intravenously on labour progression compared to placebo&#xD;
&#xD;
        -  To establish the dose-response curve of single bolus doses of FE200440 administered&#xD;
           intravenously in terms of time to delivery, uterine contractions and labour progression&#xD;
&#xD;
        -  To determine the duration of action of four different single bolus doses of FE200440&#xD;
           administered intravenously in terms of time to delivery, uterine contractions and labour&#xD;
           progression&#xD;
&#xD;
        -  To establish the pharmacokinetic parameters of FE200440 after single bolus intravenous&#xD;
           administration&#xD;
&#xD;
        -  To determine the relation between plasma concentrations of FE200440 and uterine&#xD;
           contractions and labour progression&#xD;
&#xD;
        -  To compare the maternal, fetal and infant safety profile after intravenous&#xD;
           administration of four different single bolus doses of FE200440 and placebo&#xD;
&#xD;
        -  To evaluate the impact of four different single bolus doses of FE200440 administered&#xD;
           intravenously on delivery outcome, postpartum events and lactation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Actual">163</enrollment>
  <condition>Labor, Premature</condition>
  <condition>Premature Birth</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FE200440</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signed Informed Consent Form, prior to screening evaluations&#xD;
&#xD;
          2. Mother and fetus in good general health&#xD;
&#xD;
          3. Pregnant women age ≥ 18 years&#xD;
&#xD;
          4. Gestational age (verified by early ultrasound or if an ultrasound is not available by&#xD;
             Last Menstrual Period) between 34 weeks + 0 days and 35 weeks + 6 days (both days&#xD;
             inclusive)&#xD;
&#xD;
          5. At randomisation, there must be 6 or more uterine contractions of at least 30 seconds&#xD;
             duration during a 30 minutes interval&#xD;
&#xD;
          6. At randomisation, the cervical length must be ≤ 15 mm (by transvaginal ultrasound)&#xD;
&#xD;
          7. At randomisation, the cervical dilatation must be &gt;1 cm and &lt;4 cm (by vaginal&#xD;
             examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications for the mother or the fetus to stop labour, including&#xD;
&#xD;
               -  clinical suspicion of abruptio placenta&#xD;
&#xD;
               -  known or suspected infection (e.g. urinary tract infection, chorioamnionitis)&#xD;
&#xD;
          2. Controlled or uncontrolled diabetes mellitus (pre-gestational or gestational)&#xD;
&#xD;
          3. Eclampsia or severe preeclampsia in the current pregnancy&#xD;
&#xD;
          4. Previous major uterine surgery (e.g. myomectomy for leiomyomas), congenital uterine&#xD;
             abnormalities, large leiomyomas, or retained intrauterine device&#xD;
&#xD;
          5. Rupture of membrane in the current pregnancy&#xD;
&#xD;
          6. Placenta praevia in the current pregnancy&#xD;
&#xD;
          7. a)&#xD;
&#xD;
          8. Oligohydramnios or polyhydramnios in the current pregnancy defined as amniotic fluid&#xD;
             index (AFI) below 7.2 cm or above 27.8 cm&#xD;
&#xD;
          9. Fetal weight (based on ultrasound) outside the ± 2SD limits provided in Appendix B&#xD;
&#xD;
         10. Use of cervical cerclage in the current pregnancy&#xD;
&#xD;
         11. Current multiple pregnancy&#xD;
&#xD;
         12. Fetal death in utero in previous or current pregnancy&#xD;
&#xD;
         13. Fetus with known or suspected abnormal karyotype or major malformations in the current&#xD;
             pregnancy&#xD;
&#xD;
         14. Abnormal fetal heart rate which the Investigator judges to reflect fetal distress&#xD;
&#xD;
         15. Treatment with nifedipine, non-steroidal anti-inflammatory agents (NSAIDs) or&#xD;
             intravenously administered magnesium sulphate for contractions during the current&#xD;
             pregnancy or treatment with beta-mimetics, atosiban or progesterone within the last 7&#xD;
             days prior to randomisation&#xD;
&#xD;
         16. Treatment with anticoagulation or fibrinolytic therapies prior to screening, or known&#xD;
             or suspected or past history of thromboembolic disorders&#xD;
&#xD;
         17. Known, suspected or past history of hypocoagulability or coagulation deficiency&#xD;
             conditions&#xD;
&#xD;
         18. Known or suspected hemoglobinopathies&#xD;
&#xD;
         19. Use of any investigational drug during the current pregnancy&#xD;
&#xD;
         20. Known, suspected or past history (last 12 months) of alcohol or drug abuse&#xD;
&#xD;
         21. Known hypersensitivity to the active ingredient or to any of its excipients&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Clinical Development Support</last_name>
    <role>Study Director</role>
    <affiliation>Ferring Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ULB Erasme Hospital Gynecology, Route de Lennik 808</name>
      <address>
        <city>Brussels</city>
        <zip>BE-1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Citadelle, Boulevard du 12iede Ligne 1</name>
      <address>
        <city>Liege</city>
        <zip>BE-4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Heilig Hart Gynecology, Kliniekstraat 44</name>
      <address>
        <city>Tienen</city>
        <zip>BE-3299</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicko-porodnicka klinika Fakultni nemocnice Brno, Obilni trh 11</name>
      <address>
        <city>Brno</city>
        <zip>CZ-625 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicko-porodnicke oddeleni nemocnice Jihlava, Vrchlickeho 59</name>
      <address>
        <city>Jihlava</city>
        <zip>CZ-58 501</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicka-porodnicka klinika Fakultni nemocnice, Capkovo namesti 1</name>
      <address>
        <city>Plzen</city>
        <zip>CZ-307 08</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicko-porodnicka klinika 1. LF UK a VFN v Praze, Apolinarska 18</name>
      <address>
        <city>Praha 2</city>
        <zip>CZ-128 51</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicko-porodnicka klinika Fakultni nemocnice Motol, V uvalu 84</name>
      <address>
        <city>Praha 5</city>
        <zip>CZ-15006</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynekologicko.porodnicke oddeleni, Socialni pece 12A</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>CZ-400 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hopital</name>
      <address>
        <city>Kuopio</city>
        <zip>FI-70210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>FI-33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital, Kiinamyllynkatu 4-6</name>
      <address>
        <city>Turku</city>
        <zip>FIN-20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaunas Medical University Clinics, Eiveniu 2</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius University, Antakalnio 57</name>
      <address>
        <city>Vilnius</city>
        <zip>LT-10207</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zaklad Patofizjologii Ciazy AM w Bialymstoku, M.C. Sklodowskiej 24a</name>
      <address>
        <city>Bialystok</city>
        <zip>PO - 15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta &quot;Elias&quot;, Nr. 17, Str. Marasti, sector 1</name>
      <address>
        <city>Bucuresti</city>
        <zip>RO-011461</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean Cluj-Napoca Ginecologie No. 1, Clinica Nr. 1 Ginecologie Nr. 3-5, Str. Clinicilor</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>RO-3400</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Finland</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>Romania</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>December 15, 2011</last_update_submitted>
  <last_update_submitted_qc>December 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

